Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Clinical trial NCT07206758 · RECRUITING

Trial details

NCT number: NCT07206758
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2025-11-12
Primary completion: 2026-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.